Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
Ab116779-10μl | 10μl | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $69.90 | |
Ab116779-50μl | 50μl | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $199.90 | |
Ab116779-100μl | 100μl | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $309.90 | |
Ab116779-1ml | 1ml | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $2,799.90 |
Recombinant; Rabbit anti Human MYL9 Antibody; WB; Unconjugated
Product Name | Recombinant MYL9 Antibody - Primary antibody, specific to MYL9, Rabbit IgG |
---|---|
Synonyms | 20 kDa myosin light chain | LC20 | MLC-2C | Myosin regulatory light chain 2, smooth muscle isoform | Myosin regulatory light chain 9 | Myosin regulatory light chain MRLC1 | Myosin RLC | MYL9 | LC20 | MLC-2C | MLC2 | MMIHS4 | MRLC1 | MYRL2 | 20 kDa myosin |
Specifications & Purity | ExactAb™, Validated, Recombinant, 1.2 mg/mL |
Host species | Rabbit |
Specificity | MYL9 |
Immunogen | A synthetic peptide derived from human MYL9 (AA 60-80) |
Positive Control | WB: A431, HeLa and U-2 OS cell lysates. |
Conjugation | Unconjugated |
Grade | ExactAb™, Recombinant, Validated |
Product Description | Rabbit anti Human MYL9 Antibody, Recombinant, could be used for WB and so on. |
Isotype | Rabbit IgG |
---|---|
Light Chain Type | kappa |
SDS-PAGE | 150 kDa |
Purification Method | Protein A purified |
Form | Liquid |
Concentration | 1.2 mg/mL |
Storage Temp | Store at -20°C,Avoid repeated freezing and thawing |
Shipped In | Ice chest + Ice pads |
Stability And Storage | Store at 4°C short term (1-2 weeks). Store at -20°C long term (24 months). Upon delivery aliquot. Avoid freeze/thaw cycle. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Application | Dilution info |
---|---|
WB | 1/500-1/1000"> 1/500-1/1000 |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
ZJ24F0708950 | Certificate of Analysis | Jul 29, 2024 | Ab116779 |
ZJ24F0708949 | Certificate of Analysis | Jul 29, 2024 | Ab116779 |
1. Deloukas P, Matthews LH, Ashurst J, Burton J, Gilbert JG, Jones M, Stavrides G, Almeida JP, Babbage AK, Bagguley CL, Bailey J, Barlow KF, Bates KN, Beard LM, Beare DM, Beasley OP, Bird CP, Blakey SE, Bridgeman AM, Brown AJ, Buck D, Burrill W, Butler AP, Carder C, Carter NP, Chapman JC, Clamp M, Clark G, Clark LN, Clark SY, Clee CM, Clegg S, Cobley VE, Collier RE, Connor R, Corby NR, Coulson A, Coville GJ, Deadman R, Dhami P, Dunn M, Ellington AG, Frankland JA, Fraser A, French L, Garner P, Grafham DV, Griffiths C, Griffiths MN, Gwilliam R, Hall RE, Hammond S, Harley JL, Heath PD, Ho S, Holden JL, Howden PJ, Huckle E, Hunt AR, Hunt SE, Jekosch K, Johnson CM, Johnson D, Kay MP, Kimberley AM, King A, Knights A, Laird GK, Lawlor S, Lehvaslaiho MH, Leversha M, Lloyd C, Lloyd DM, Lovell JD, Marsh VL, Martin SL, McConnachie LJ, McLay K, McMurray AA, Milne S, Mistry D, Moore MJ, Mullikin JC, Nickerson T, Oliver K, Parker A, Patel R, Pearce TA, Peck AI, Phillimore BJ, Prathalingam SR, Plumb RW, Ramsay H, Rice CM, Ross MT, Scott CE, Sehra HK, Shownkeen R, Sims S, Skuce CD, Smith ML, Soderlund C, Steward CA, Sulston JE, Swann M, Sycamore N, Taylor R, Tee L, Thomas DW, Thorpe A, Tracey A, Tromans AC, Vaudin M, Wall M, Wallis JM, Whitehead SL, Whittaker P, Willey DL, Williams L, Williams SA, Wilming L, Wray PW, Hubbard T, Durbin RM, Bentley DR, Beck S, Rogers J. (2001) The DNA sequence and comparative analysis of human chromosome 20.. Nature, 414 (6866): (865-71). [PMID:11780052] [10.1021/op500134e] |
2. Kumar, C C CC, Mohan, S R SR, Zavodny, P J PJ, Narula, S K SK and Leibowitz, P J PJ.. (1989) Characterization and differential expression of human vascular smooth muscle myosin light chain 2 isoform in nonmuscle cells.. Biochemistry, (2): [PMID:2526655] |
3. Iwasaki, T T, Murata-Hori, M M, Ishitobi, S S and Hosoya, H H.. (2001) Diphosphorylated MRLC is required for organization of stress fibers in interphase cells and the contractile ring in dividing cells.. Cell structure and function, [PMID:11942626] |
4. Tan, Ivan I, Yong, Jeffery J, Dong, Jing Ming JM, Lim, Louis L and Leung, Thomas T.. (2008) A tripartite complex containing MRCK modulates lamellar actomyosin retrograde flow.. Cell, (3): [PMID:18854160] |
5. Shoval, Yishay Y, Berissi, Hanna H, Kimchi, Adi A and Pietrokovski, Shmuel S.. (2011) New modularity of DAP-kinases: alternative splicing of the DRP-1 gene produces a ZIPk-like isoform.. PloS one, (8): [PMID:21408167] |
6. Tan, Ivan I, Lai, Jesyin J, Yong, Jeffery J, Li, Sam F Y SF and Leung, Thomas T.. (2011) Chelerythrine perturbs lamellar actomyosin filaments by selective inhibition of myotonic dystrophy kinase-related Cdc42-binding kinase.. FEBS letters, (6): [PMID:21457715] |
7. Moreno, Carolina Araujo CA and 6 more authors.. (2018) Homozygous deletion in MYL9 expands the molecular basis of megacystis-microcolon-intestinal hypoperistalsis syndrome.. European journal of human genetics : EJHG, [PMID:29453416] |
8. Kandler, Justin L and 5 more authors.. (2020) Compound heterozygous loss of function variants in MYL9 in a child with megacystis-microcolon-intestinal hypoperistalsis syndrome.. Molecular genetics & genomic medicine, [PMID:33031641] |